The pathophysiology of heart failure with preserved ejection fraction

Nature Reviews Cardiology

Volumn 11, Issue 9, 2014, Pages 507-515

  Borlaug, Barry A ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

AGING; CHRONOTROPISM; COMORBIDITY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART BUNDLE BRANCH BLOCK; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART FUNCTION; HEART RIGHT VENTRICLE FAILURE; HUMAN; HYPERTENSION; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

HEART FAILURE; HUMANS; RISK FACTORS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84906937269     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2014.83     Document Type: Review

References (137)

1. WHO. Cardiovascular diseases. Fact sheet number 317 [online], http://www.who.int/mediacentre/factsheets/fs317/en/(2013).
2. Braunwald, E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N. Engl. J. Med. 337, 1360-1369 (1997).
3. Heidenreich, P. A. et al . Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ. Heart Fail. 6, 606-619 (2013).
4. Owan, T. E. et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 355, 251-259 (2006).
5. Borlaug, B. A. & Paulus, W. J. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur. Heart J. 32, 670-679 (2011).
6. Lee, D. S. et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute. Circulation 119, 3070-3077 (2009).
7. Bhatia, R. S. et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N. Engl. J. Med. 355, 260-269 (2006).
8. Bursi F.,et al Systolic and diastolic heart failure in the community JAMA 296 2209-2216 2006).
9. Kitzman, D. W., Higginbotham, M. B., Cobb, F. R., Sheikh, K. H. & Sullivan, M. J. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J. Am. Coll. Cardiol. 17, 1065-1072 (1991).
10. Hundley, W. G. et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J. Am. Coll. Cardiol. 38, 796-802 (2001).
11. Yip, G. et al. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart 87, 121-125 (2002).
12. Yu, C. M. et al. Progression of systolic abnormalities in patients with " isolated" diastolic heart failure and diastolic dysfunction. Circulation 105, 1195-1201 (2002).
13. Kawaguchi, M., Hay, I., Fetics, B. & Kass, D. A. Combined ventricular systolic and arterial stiffening in patients with heart fai lure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 107, 714-720 (2003).
14. Zile, M. R., Baicu, C. F. & Gaasch, W. H. Diastolic heart f ailure-Abnormalities in active relaxation and passive stiffness of the left ventricle. N. Engl. J. Med. 350, 1953-1959 (2004).
15. Borlaug, B. A. et al. Impaired chronotropic and vasodilator reserves limit ex ercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 114, 2138-2147 (2006).
16. Brubaker, P. H. et al. Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. J. Cardiopulm. Rehabil. 26, 86-89 (2006).
17. Tan, Y. T. et al. The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography revea ls complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J. Am. Coll. Cardiol. 54, 36-46 (2009).
18. Melenovsky, V. et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunc tion. J. Am. Coll. Cardiol. 49, 198-207 (2007).
19. Lam, C. S. et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 115, 1982-1990 (2007).
20. Fung, J. W., Sanderson, J. E., Yip, G. W., Zhang, Q. & Yu, C. M. Impact of atrial fibrillation in heart failure with normal ejection fractio n: a clinical and echocardiographic study. J. Card. Fail. 13, 649-655 (2007).
21. Ennezat, P. V. et al. Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. J. Card. Fail. 14, 475-480 (2008).
22. Westermann, D. et al. Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 117, 2051-2060 (2008).
23. Borlaug, B. A., Lam, C. S., Roger, V. L., Rodeheffer, R. J. & Redfield, M. M. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J. Am. Coll. Cardiol. 54, 410-418 (2009).
24. Phan, T. T. et al. Heart failure with preserved ejection fraction is characterized by dynamic imp airment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J. Am. Coll. Cardiol. 54, 402-409 (2009).
25. Wachter, R. et al. Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure. Eur. Heart J. 30, 3027-3036 (2009).
26. Lam, C. S. et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J. Am. Coll. Cardiol. 53, 1119-1126 (2009).
27. Borlaug, B. A. et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J. Am. Coll. Cardiol. 56, 845-854 (2010).
28. Maeder, M. T., Thompson, B. R., Brunner-La Rocca, H. P. & Kaye, D. M. Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J. Am. Coll. Cardiol. 56, 855-863 (2010).
29. Borlaug B. A., Nishimura R. A., Sorajja P., Lam , C. S., Redfield, M. M. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction . Circ. Heart Fail. 3 588-595 2010).
30. Tan, Y. T. et al. Reduce d left atrial function on exercise in patients with heart failure and normal ejection fraction. Heart 96, 1017-1023 (2010).
31. Prasad, A. et al. Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction. Circ. Heart Fail. 3, 617-626 (2010).
32. Lee, A. P. et al. Importance of dynamic dyssynchrony in the occurrence of hypertensive heart failure with normal ejection fraction. Eur. Heart J. 31, 2642-2649 (2010).
33. Borlaug, B. A. et al. Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction. Heart 97, 964-969 (2011).
34. Shibata, S. et al. Congestive heart failure with preserved ejection fraction is associated with severely impaired dynamic Starling mechanism. J. Appl. Physiol. 110, 964-971 (2011).
35. Haykowsky, M. J. et al. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J. Am. Coll. Cardiol. 58, 265-274 (2011).
36. Bhella, P. S. et al. Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur. J. Heart Fail. 13, 1296-1304 (2011).
37. Yip, G. W. et al. Resting global and regional left ventricular contractility in patients with heart failure and normal ejection fraction: insights from speckle-tracking echocardiography. Heart 9 7, 287-294 (2011).
38. Tartiére-Kesri, L., Tartiére, J. M., Logeart, D., Beauvais, F. & Cohen Solal, A. Increased proximal arterial stiffness and cardiac response with moderate exercise in p atients with heart failure and preserved ejection fraction. J. Am. Coll. Cardiol. 59, 455-461 (2012).
39. Haykowsky, M. J. et al. Impaired aerobic cap acity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass. J. Gerontol. A Biol. Sci. Med. Sci. 68, 968-975 (2013).
40. Abudiab, M. M. et al. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur. J. Heart Fail. 15, 776-785 (2013).
41. Tan, Y. T., Wenzelburger, F. W ., Sanderson, J. E. & Leyva, F. Exercise-induced torsional dyssynchrony relates to impaired functional capacity in patients with heart failure and normal ejection fraction. Heart 99, 259-266 (2013).
42. Mau rer, M. S., Teruya, S., Chakraborty, B., Helmke, S. & Mancini, D. Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and effica cy. Circ. Heart Fail. 6, 254-263 (2013).
43. Shah, A. M. et al. Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of th e treatment of preserved cardiac function heart failure with an aldosterone antagonist trial. Circ. Heart Fail. 7, 104-115 (2014).
44. Kraigher-Krainer, E. et al. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J. Am. Coll. Cardiol. 63, 447-456 (2014).
45. Santos, A. B. et al. Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction. Eur. Heart J. 35, 42-47 (2014).
46. Borlaug, B. A. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction. Circ. J. 78, 20-32 (2013).
47. Stratton, J. R., Levy, W. C., Cerqueira, M. D., Schwartz, R. S. & Abrass, I. B. Cardiovascular responses to exercise. Effects of aging and exercise training in healthy men. Circulation 89, 1648-1655 (1994).
48. Fleg, J. L. et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J. Appl. Physiol. 78, 890-900 (1995).
49. DeSouza, C. A. et al. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 102, 1351-1357 (2000).
50. Arbab-Zadeh, A. et al. Effect of aging and physical activity on left ventricular compliance. Circulation 110, 1799-1805 (2004).
51. Popović Z. B.,et al Relationship among diastolic intraventricular pressure gradients, relaxation, and preload: impact of age and fitness. Am. J. Physiol. Heart Circ. Physiol. 290 H1454-H1459 2006).
52. Prasad, A. et al. The effects of aging and physical activity on Doppler measures of diastolic function. Am. J. Cardiol. 99, 1629-1636 (2007).
53. Carrick-Ranson, G. et al. Effect of healthy aging on left ventricular relaxation and diastolic suction. Am. J. Physiol. Heart Circ. Physiol. 303, H315-H322 (2012).
54. Fujimoto, N. et al. Effect of ageing on left ventricular compliance and distensibility in healthy sedentary humans. J. Physiol. 590, 1871-1880 (2012).
55. Borlaug, B. A. et al. Longitudinal changes in left ventricular stiffness: a community-based study. Circ. Heart Fail. 6, 944-952 (2013).
56. Wohlfahrt, P. et al. Impact of general and central adiposity of ventricular-Arterial aging in women and men. JACC Heart Fail. (in press).
57. Gerhard, M., Roddy, M. A., Creager, S. J. & Creager, M. A. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 2 7, 849-853 (1996).
58. Topol, E. J., Traill, T. A. & Fortuin, N. J. Hypertensive hypertrophic cardiomyopathy of the elderly. N. Engl. J. Med. 312, 277-283 (1985).
59. Zile, M. R. et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 104, 779-782 (2001).
60. Zile, M . R. et al. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 124, 2491-2501 (2011).
61. va n Heerebeek, L. et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113, 1966-1973 (2006).
62. Borbé ly, A. et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation 111, 774-781 (2005).
63. Borlaug, B. A. & Kass, D. A. Invasive hemodynamic assessment in heart failure. Cardiol. Clin. 29, 269-280 (2011).
64. Borlaug, B. A. & Kass, D. A. Mechanisms of diastolic dysfunction in heart failure. Trends Cardiovasc. Med. 16, 273-279 (2006).
65. Hay, I., Rich, J., Ferber, P., Burkhof f, D. & Maurer, M. S. Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure. Am. J. Physiol. Heart Circ. Physiol. 288, H1203-H1208 (2005).
66. Nonogi, H., Hess, O. M., Ritter, M. & Krayenbuehl, H. P. Diastolic properties of the normal left ventricle during supine exercise. Br. Heart J. 60, 30-38 (1988).
67. Udelson, J. E., Bacharach, S. L., Cannon, R. O. 3rd & Bonow, R. O. Minimum left ventricular pressure during beta-Adrenergic stimulation in human subjects. Evidence for elastic recoil and diastolic "suction " in the normal heart. Circulation 82, 1174-1182 (1990).
68. Cheng, C. P., Igarashi, Y. & Little, W. C. Mechanism of augmented rate of left ventricular filling during exercise. Circ. Res. 70, 9-19 (1992).
69. Cheng, C. P., Noda, T., Nozawa, T. & Little, W. C. Effect of heart failure on the mechanism of exercise-induced augmentation of mitral valve flow. Circ. Res. 72, 795-806 (1993) .
70. Tan, Y. T. et al. Abnormal left ventricular function occurs on exercise in well-treated hypertensive subjects with normal resting echocardiography. Heart 96, 948-955 (2010).
71. Ohara, T. et al. Loss of adrenergic augmentation of diastolic intra-LV pressure difference in patients with diastolic dysfunction: evaluation by color M-mode echocardiography. JACC Cardiovasc. Imaging 5, 861-870 (2012).
72. Opdahl A.,et al Determinants of left ventricular early-diastolic lengthening velocity: independent contributions from left ventricular relaxation, restoring forces, and lengthening load Circulation 119 2578-2586 2009)
73. Opdahl, A., Remme, E. W., Helle-Valle, T., Edvardsen, T. & Smiseth, O. A. Myocardial relaxation, restoring forces, and early-diastolic load are independent determinant s of left ventricular untwisting rate. Circulation 126, 1441-1451 (2012).
74. van Heerebeek, L. et al. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation 126, 830-839 (2012).
75. Paulus, W. J. & Tschö pe, C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J. Am. Coll. Cardiol. 62, 263-271 (2013).
76. LeWinter, M. M. & Granzier, H. Cardiac titin: a multifunctional giant. Circulation 121, 2137-2145 (2010).
77. Hidalgo, C. & Granzier, H. Tun ing the molecular giant titin through phosphorylation: role in health and disease. Trends Cardiovasc. Med. 23, 165-171 (2013).
78. Persson, H. et al. Diastolic dysfunction in heart failure with preserv ed systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES. J. Am. Coll. Cardiol. 49, 687-694 (2007).
79. Anjan, V. Y. et al. Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction. Am. J. Cardiol. 110, 870-876 (2012).
80. Wang, T. J. et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 109, 594-600 (2004).
81. Bertoni, A. G. et al. Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes. Obesity (Silver Spring) 20, 1511-1518 (2012).
82. Maurer, M. S. et al. Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J. Am. Coll. Cardiol. 49, 972-981 (2007).
83. Abraham, W. T. et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377, 658-666 (2011).
84. Petrie, M. C ., Caruana, L., Berry, C. & McMurray, J. J. " Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction? Heart 87, 29-31 (2002).
85. Dunlay, S. M., Roger, V. L., Weston, S. A., Jiang, R. & Redfield, M. M. Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ. Heart Fail. 5, 720-726 (2012).
86. Hwang, S. J., Melenovsky, V. & Borlaug, B. A. Implications of coronary artery disease in heart failure with preserved ejection fraction. J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2014.03.034.
87. Tan, Y. T. et al. Abnormal left ventricular function occurs on exercise in well-treated hypertensive subjects with normal resting echocardiography. Heart 96, 948-955 (2010).
88. Yu, C. M. et al. Diastolic and systolic asynchrony in patients with diastolic heart failure: a common but ignored condition. J. Am. Coll. Cardiol. 49, 97-105 (2007).
89. Phan, T. T. et al. Increased atrial contribution to left ventricular filling compensates for impaired early filling during exercise in heart failure with preserved ejection fraction. J. Card. Fail. 15, 890-897 (2009).
90. Zakeri, R. et al. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ. Heart Fail. 7, 123-130 (2014).
91. Melenovsky, V., Hwang, S.-J., Lin, G., Redfield, M. M. & Borlaug, B. A. Right heart dysfunction in heart failure with preserved ejection fraction. Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/ehu193.
92. Zakeri, R., Chamberlain, A. M., Roger, V. L. & Redfield, M. M. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation 128, 1085-1093 (2013).
93. Tsang T. S., Barnes M. E., Gersh B. J., Bailey K. R., Seward J. B Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am. J. Ca rdiol. 90 1284-1289 2002).
94. Guazzi, M. & Borlaug, B. A. Pulmonary hypertension due to left heart disease. Circulation 126, 975-990 (2012).
95. Tedford, R. J. et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 125, 289-297 (2012).
96. Schwartzenberg, S. et al. E ffects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J. Am. Coll. Cardiol. 59, 442-451 (2012).
97. Hawkins, N. M . et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur. J. Heart Fail. 11, 130-139 (2009).
98. Schwarz, K., Singh, S., Dawson, D. & Frenneaux, M. P. Right ventricular function in left ventricular disease: pathophysiology and implications. Heart Lung Circ. 22, 507-511 (2013).
99. Burke, M. A. et al. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ. Heart Fail. 7, 288-299 (2014).
100. Liu, M. et al. Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur. J. Heart Fail. 14, 39-44 (2012).
101. Melenovsky, V. et al. Relationships between right ventricular function, body composition, and prognosis in advanced heart failure. J. Am. Coll. Cardiol. 62, 1660-1670 (2013).
102. Redfield, M. M. et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309, 1268-1277 (2013).
103. Janicki, J. S. Influence of the pericardium an d ventricular interdependence on left ventricular diastolic and systolic function in patients with heart failure. Circulation 81 (2 Suppl.), III15-III20 (1990).
104. Dauterman, K. et al. Contribution of external for ces to left ventricular diastolic pressure. Implications for the clinical use of the Starling law. Ann. Intern. Med. 122, 737-742 (1995).
105. Stray-Gundersen, J. et al. The effect of pericardiectomy on maximal oxygen consumption and maximal cardiac output in untrained dogs. Circ. Res. 58, 523-530 (1986).
106. Akiyama, E. et al. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. J. Am. Coll. Cardiol. 60, 1778-1786 (2012).
107. Haykowsky, M. J. et al. Relationship of flow-mediated arterial dilation and exercise capacity in older patients with heart failure and preserved ejection fraction. J. Gerontol. A Biol. Sci. Med. Sci. 68, 161-167 (2013).
108. Leite-Moreira, A. F. et al. Diastolic tolerance to systolic pressures closely reflects systolic performance in patients with coronary heart disease. Basic Res. Cardiol. 107, 251 (2012).
109. Chirinos, J. A. et al. Early and late systolic wall stress differentially relate to myocardial contraction and relaxation in middle-Aged adults: the Asklepios study. Hypertension 61, 296-303 (2013).
110. Borlaug, B. A. et al. Impact of arterial load and loading sequence on left ventricular tissue velocities in humans. J. Am. Coll. Cardiol. 50, 1570-1577 (2007).
111. Phan, T. T. et al. Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction. Circ. Heart Fail. 3, 29-34 (2009).
112. Kosmala, W. et al. Effect of I f-channel Inhibition on hemodynamics and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial. J. Am. Coll. Cardiol. 62, 1330-1338 (2013).
113. Cole, C. R., Blackstone, E . H., Pashkow, F. J., Snader, C. E. & Lauer, M. S. Heart-rate recovery immediately after exercise as a predictor of mortality. N. Engl. J. Med. 341, 1351-1357 (1999).
114. Schlaich, M. P. et a l. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 108, 560-565 (2003).
115. Funakoshi K., Hosokawa K., Kishi T., Ide T., Sunagawa K. Striking volume intolerance is induced by mimicking arterial baroreflex failure in normal left ventricular function J. Card. Fail. 20 53-59 2014).
116. Floras, J. S. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J. Am. Coll. Cardiol. 54, 375-385 (2009).
117. Kitzman, D. W. et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288, 2144-2150 (2002).
118. Haykowsky, M. J. et al. Effect of endurance training on the determinants of peak exercise oxygen consumption in eld erly patients with stable compensated heart failure and preserved ejection fraction. J. Am. Coll. Cardiol. 60, 120-128 (2012).
119. Vogiatzis, I. & Zakynthinos, S. The physiological basis of rehabilitation in chronic heart and lung disease. J. Appl. Physiol. (1985) 115, 16-21 (2013).
120. Shah, S. J. Matchmaking for the optimization of heart failure with preserved ejection fraction clinical trials: no laughing matter. J. Am. Coll. Cardiol. 62, 1339-1342 (2013).
121. Haykowsky, M. J. et al. Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction. Am. J. Cardiol. 113, 1211-1216 (2014).
122. Kitzman, D. W. et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and pres erved ejection fraction. Am. J. Physiol. Heart Circ. Physiol. 306, H1364-H1370 (2014).
123. Poole, D. C., Hirai, D. M., Copp, S. W. & Musch, T. I. Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance. Am. J. Physiol. Heart Circ. Physiol. 302, H1050-H1063 (2012).
124. Borlaug, B. A. Heart failure with preserved and reduced ejection fraction: different risk profiles for different diseases. Eur. Heart J. 34, 1393-1395 (2013).
125. Dai, D. F., Rabinovitch, P. S. & Ungvari, Z. Mitochondria and cardiovascular aging. Circ. Res. 110, 1109-1124 (2012).
126. Bergmann, O . et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98-102 (2009).
127. Biernacka, A. & Frangogiannis, N. G. Aging and cardiac fibrosis. Aging Dis. 2, 158-173 (2011).
128. Pillai, V. B., Sundaresan, N. R. & Gupta, M. P. Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging. Circ. Res. 114, 368-378 (2014).
129. Boon, R. A. et al. MicroRNA-34a regulates cardiac ageing and function. Nature 495, 107-110 (2013).
130. Madeo, F., Tavernarakis, N. & Kroemer, G. Can autophagy promote longevity? Nat. Cell Biol. 12, 842-846 (2010).
131. Loffredo, F. S. et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153, 828-839 (2013).
132. Rider, O. J. et al. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J. Am. Coll. Cardiol. 54, 718-726 (2009).
133. Lavie, C. J., McAuley, P. A., Church, T. S., Milani, R. V. & Blair, S. N. Obesity and cardiovascular diseases-implications regarding fitness, fatness and severity in the obesity paradox. J. Am. Coll. Cardiol . 63, 1345-1354 (2014).
134. Rider, O. J. et al. Effects of catecholamine stress on diastolic function and myocardial energetics in obesity. Circulation 125, 1511-1519 (2012).
135. Kozakova, M. et al. Reduced left ventricular functional reserve in hypertensive patients with preserved function at rest. Hypertension 45, 619-624 (2005).
136. Norman H. S.,et al Decreased cardiac functional reserve in heart failure with preserved systolic function. J. Card. Fail. 17 301-308 2011).
137. Nelson, M. D. et al. Diastolic dysfunction in women with signs and symptoms of ischemia in the absence of obstructive coronary artery disease: a hypothesis-generating study. Circ. Cardiovasc. Imaging 7, 510-516 (2014).